Novartis Upgrades FullYear Guidance on Sales and Profit Outlook INGR Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures Kazatomprom Reports 17 Production Increase in Third Quarter Highlighting Operational Gains